Evidence map›Paper›PMID 32762055›Full record

ReviewClinical transplantation2020

The COVID-19 pandemic: A community approach.

Paolo Cravedi, Jesse D Schold, Kassem Safa, Olivia S Kates, Nissreen Elfadawy, Roslyn B Mannon, Malay B Shah, Sarah P Hammond, Robin Avery, Cesar Guerrero Miranda and 6 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Review
  5. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Review
  6. Review
  7. Article
  8. The COVID-19 pandemic: A community approach.Clinical transplantation · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Paolo CravediDepartment of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.ORCID 0000-0001-7837-0923
Jesse D ScholdDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Kassem SafaTransplant Center and Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9283-7662
Olivia S KatesDivision of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.ORCID 0000-0003-4381-0049
Nissreen ElfadawyDivision of Nephrology, Hypertension and Kidney Transplant, Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland, OH, USA.ORCID 0000-0002-7056-443X
Roslyn B MannonDivision of Nephrology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0003-1776-3680
Malay B ShahDivision of Transplantation, Department of Surgery, University of Kentucky Medical Center, Lexington, KY, USA.
Sarah P HammondDivision of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Robin AveryDivision of Infectious Diseases, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Cesar Guerrero MirandaBaylor Scott and White Heart and Vascular Hospital, Dallas, TX, USA.
Leonardo V RiellaTransplanation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7636-3196
Sheila Jowsey-GregoireDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Enver AkalinAlbert Einstein College of Medicine, Montefiore Medical Center, New York City, NY, USA.
Geoffrey CamirandThe Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical, Pittsburgh, PA, USA.
Maria-Luisa AlegreDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Jamil AzziTransplanation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6909-4645

Funding

Impact of Microbiota on Alloimmune Responses in TransplantationR01AI115716 · NIAID · UNIVERSITY OF CHICAGO · PI ALEGRE, MARIA-LUISA · 2015 to 2024
$4.3M
Training Program in Infectious Diseases in the Immunocompromised HostT32AI118690 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2016 to 2025
$4.0M
NIAID NIH HHS R01 AI115716NIAID NIH HHS T32 AI118690
6 · The paper itself

Abstract

An unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community "Outstanding Questions in Transplantation," hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature.

Indexed as

COVID-19Organ TransplantationPandemicsPostoperative ComplicationsSARS-CoV-2Global HealthGraft RejectionHumansImmunocompromised HostImmunosuppressive AgentsInternational CooperationSocieties, MedicalImmunosuppressive Agentsimmune deficiencyimmunosuppressantinfection and infectious agents

Identifiers

PMID32762055
PMCPMC7435543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.